Two Rare Tumors in One Child’s Eye Socket Puzzle Doctors

When an 11-year-old child arrived at the ophthalmology clinic with a right eye that was gradually bulging forward, accompanied by redness, sensitivity to light, and constant tearing, the clinical team expected to find a single culprit. What they ultimately discovered, and what surgeons and pathologists confirmed over the course of three years, was something no one had documented before in a pediatric patient: two entirely different tumors growing side by side in the same orbit, one wrapped around the optic nerve sheath and the other embedded within an extraocular muscle. The case, reported by Hao Zhang and Weimin He of the Department of Ophthalmology at West China Hospital of Sichuan University in Chengdu, China, and published in BMC Pediatrics, offers a rare window into how two biologically unrelated neoplasms can coexist in the confined anatomy of a child’s eye socket, and it raises difficult questions about diagnosis, genetics, and the ethics of long-term surveillance.

The story began with progressive proptosis, the medical term for the forward displacement of the eyeball out of its socket. Proptosis in children is never a finding to take lightly. The orbit is a rigid bony cavity with a fixed volume, so any expanding lesion, whether inflammatory, vascular, or neoplastic, has nowhere to go except forward, pushing the globe ahead of it. The accompanying symptoms of redness, photophobia, and tearing suggested active irritation of the ocular surface and possibly mechanical compression of surrounding structures. Orbital examination revealed two distinct abnormalities: thickening of the right lateral rectus muscle, one of the six muscles responsible for moving the eye, and a retrobulbar lesion, a mass sitting behind the eyeball in the space between the globe and the orbital apex.

Imaging alone could not settle the question of what these lesions were. The differential diagnosis for a thickened extraocular muscle in a child includes inflammatory myositis of the muscle, thyroid eye disease, and neoplastic infiltration, while a retrobulbar mass in the same age group could be an optic pathway glioma, a rhabdomyosarcoma, a vascular malformation, or any of a dozen other entities. The only way to know was to obtain tissue. Under general anesthesia, the surgical team performed a retrobulbar resection and a biopsy of the lateral rectus muscle. Histopathological examination of the specimens produced a result that immediately complicated the clinical picture: the lateral rectus muscle harbored a schwannoma, while the retrobulbar lesion was an atypical meningioma.

A schwannoma is a tumor of Schwann cells, the glial cells that form the myelin sheath around peripheral nerves. These tumors are typically benign and slow-growing, and they most often arise along the vestibular nerves of the inner ear or the peripheral nerves of the limbs. Finding one inside an extraocular muscle is itself unusual, because the nerves supplying these muscles are small and the intramuscular nerve branches that could give rise to a schwannoma are correspondingly tiny. An atypical meningioma, by contrast, is a tumor of meningothelial cells, the same cells that form the coverings of the brain and spinal cord. Within the orbit, meningiomas most commonly arise from the sheath that wraps the optic nerve, which is an extension of the meninges covering the brain. The designation of atypical refers to a World Health Organization grade 2 classification, indicating a tumor with increased mitotic activity or other histological features that confer a higher risk of recurrence than a completely benign grade 1 meningioma.

The coexistence of these two tumor types in a single pediatric orbit immediately triggered a specific suspicion in the minds of the clinicians: neurofibromatosis type 2, commonly abbreviated NF2. This hereditary syndrome is caused by mutations in the NF2 gene on chromosome 22, which encodes a protein called merlin that acts as a tumor suppressor regulating cell growth and contact inhibition. Patients with NF2 characteristically develop bilateral vestibular schwannomas, meningiomas, ependymomas, and schwannomas of other cranial and spinal nerves. The combination of a schwannoma and a meningioma in the same patient is a classic presentation of the syndrome, and in a child it would be particularly concerning, because NF2-related tumors tend to appear early and multiply over time. The researchers therefore placed NF2 at the top of the differential diagnosis for this patient’s dual pathology.

Careful clinical evaluation, however, failed to confirm the suspicion. There was no family history of NF2 or any other hereditary tumor syndrome. No clinical features suggestive of NF2 were identified during the initial workup or during subsequent follow-up visits. The definitive answer would have come from genetic testing for the NF2 mutation, but the patient’s family declined the test because of financial constraints, a sobering reminder that the most advanced diagnostic tools in medicine are not equally accessible to all patients. Without genetic confirmation, the clinicians could not rule NF2 in or out with certainty, and the case remained diagnostically ambiguous, forcing the team to rely on clinical observation rather than molecular certainty.

Follow-up orbital magnetic resonance imaging at three months and one year after the initial surgery showed persistent thickening of the right lateral rectus muscle and a residual retrobulbar lesion. These findings alone were not alarming, because residual tumor after partial resection is expected, and slow postoperative changes can take months to stabilize. But at the three-year mark, the MRI revealed marked enlargement of both lesions, a finding that could not be dismissed as ordinary postoperative evolution. The interpretation was tumor progression, meaning that both the schwannoma and the meningioma had resumed growth and were now larger than they had been at any point since the original intervention.

The clinical team returned to the operating room. The second surgery adopted what the authors describe as a maximal safe resection strategy, a surgical philosophy that balances the goal of removing as much tumor as possible against the imperative of preserving critical neurovascular structures. In this case, the team performed partial resection of the lateral rectus lesion, removing the bulk of the schwannoma while leaving enough of the muscle and its nerve supply intact to preserve ocular motility. The retrobulbar lesion, however, presented a far more delicate problem. Its close relationship with the optic nerve and the orbital apex meant that aggressive resection risked permanent vision loss, because the optic nerve, the cable that transmits visual information from the eye to the brain, runs directly through the territory the tumor occupied. The orbital apex, the narrow posterior opening of the orbit through which the optic nerve and the vessels and nerves supplying the eye pass, is one of the most surgically unforgiving regions in the entire body. The team therefore performed only a biopsy of the retrobulbar lesion, obtaining tissue for diagnosis without attempting to remove the mass.

Histopathological examination of the second set of specimens confirmed what the first surgery had suggested: the lateral rectus lesion was indeed a schwannoma, and the retrobulbar lesion was an optic nerve sheath meningioma. The diagnosis was now definitive, but the clinical challenge was far from resolved. Optic nerve sheath meningiomas in children are known to behave more aggressively than their adult counterparts, with higher rates of growth and a greater propensity to extend along the nerve toward the chiasm or into the cranial cavity. The atypical grade of this particular tumor, combined with its demonstrated progression over three years, placed the patient in a high-risk category requiring continued vigilance.

The authors of the report emphasize that this case demonstrates a rare coexistence of optic nerve sheath meningioma and schwannoma in a pediatric patient, a combination that has not been previously documented in the medical literature. The case highlights the complexity of diagnosing multiple orbital tumors in children, where the differential diagnosis is broad, the anatomical constraints are severe, and the stakes of surgical intervention are extraordinarily high. It also underscores the importance of careful clinical evaluation and long-term follow-up, because the natural history of these tumors can unfold over years, and the decision to intervene must be timed against the risk of progressive damage to vision and ocular motility. For the patient, the road ahead involves continued surveillance, with the knowledge that both tumors have already shown the capacity to grow and that the genetic question of NF2 remains unanswered. For the broader medical community, the case adds a new data point to the understanding of pediatric orbital neoplasms and serves as a reminder that even in an era of advanced imaging and molecular diagnostics, some clinical puzzles can only be solved through the combination of surgical courage, pathological expertise, and the patience to watch and wait.

Subject of Research: Optic nerve sheath meningioma coexisting with lateral rectus muscle schwannoma in a pediatric patient: a case report

Article Title: Optic nerve sheath meningioma coexisting with lateral rectus muscle schwannoma in a pediatric patient: a case report

Article References: Zhang, H., & He, W. (2026). Optic nerve sheath meningioma coexisting with lateral rectus muscle schwannoma in a pediatric patient: a case report. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07659-9

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07659-9

Keywords: Optic, nerve, sheath, meningioma, coexisting, lateral, rectus, muscle, schwannoma, pediatric, patient, case